|
|
 |
| For
more information about the publications listed below please contact
us by email or telephone [401 863-3875]. Some publications are available
in pdf format however the TB/HIV Lab respects pertinent copyright
law and reserves the right to refuse requests without specific reasons.
Receipt of your request in no way obligates theTB/HIV Lab to respond.
|
| Peer
Reviewed Publications |
|
1.
Quakyi IA, Otoo LN, Pombo D, Sugars LY, Menon A, Anne S. De Groot,
Johnson AH, Alling D, Miller LH, and Good MF, Differential nonresponsiveness
in humans of candidate Plasmodium falciparum vaccine antigens, Am.
J. Trop. Med. Hyg., 1989, Vol. 41, Issue 2, pp. 125-134.
2. Anne S. De Groot, Johnson AH, Maloy.WL, Quakyi IA, Riley EM,
Menon A, Banks .S M, Berzofsky JA, and Good MF, Human T cell recognition
of polymorphic epitopes from malaria circumsporozoite protein, J.
Immunol., 1989, Vol.142, No.11, pp. 4000-4005.
3. Good MF, Kumar S, Anne S. DeGroot, Weiss WR, Quakyi IA, Dontfraid
F, Smith FE, Cochran M, Berzofsky JA, Miller LH, Evidence implicating
MHC genes in the immunological nonresponsiveness to the plasmodium
falciparum CS protein, Bulletin of the World Health Organization,
68 Supplement: pp. 80-84, 1990.
4. Anne S. De Groot, Hosmalin CM, Hughes A, Barnd SH, Hendrix D,
Houghten CW, Shearer GM, Berzofsky JA, Human Immunodeficiency Virus
Reverse Transcriptase T Helper Epitopes Identified in Mice and Humans:
Correlation with a Cytotoxic T Cell Epitope, J. Infectious Disease
1991, Vol.164, pp.1058-1065.
*5. Meister GE, Roberts CGP, Berzofsky JA, Anne S. De Groot, Two
novel T cell epitope prediction algorithms based on MHC-binding
motifs; comparison of predicted and published epitopes from Mycobacterium
tuberculosis and HIV protein sequences, Vaccine 1995, Vol. 13, No.
6, pp. 581-591.
*6. Stevens J, Zierler S, Dean D, Goodman AK, Chalfen EM, Anne S.
De Groot, Prevalence of prior sexual abuse and HIV risk-taking behaviors
in incarcerated women in Massachusetts, J. Correctional Health Care,
1995, Vol. 2, Issue 2, pp. 137-149.
7. Stevens J ,Zierler S, Cram V, Dean D, Mayer KH , Anne S. De Groot,
Risks for HIV infection in incarcerated women, J. Women's Health,
1995, Vol. 4, No. 5, pp. 569-577.
8. Roberts CGP, Meister GE, Jesdale BM, Lieberman J, Berzofsky JA,
Anne S. De Groot, Predictionof HIV peptide epitopes by a novel algorithm,
AIDS Research and Human Retroviruses, 1996, Vol. 12, No. 7, pp.
593-610.
9. Anne S. De Groot, Hammett TM, Scheib RG, Barriers to Care of
HIV-Infected inmates: a public health concern, AIDS Reader, 1996,
May / June, pp. 78-87.
10. Roberts CGP, Meister GE, Jesdale BM, Lieberman J, Berzofsky
JA, Anne S. De Groot, Predictionof HIV peptide epitopes by a novel
algorithm, AIDS Research and Human Retroviruses, 1996, Vol. 12,
No. 7, pp. 593-610.
*11. De Groot,AS, Jesdale. BM, Szu, E, Schafer, JR, An interactive
web site providing MHC ligand predictions: application to HIV research,
AIDS Research and Human Retroviruses, 1997, 13: 539-541.
12. Gampper, SNR, George JA, Carter EJ, Jesdale BM, Flanigan TP,
Mayer KH, Anne S. De Groot, Co-infection with M. tuberculosis (Mtb)
and HIV in high risk clinical care settings in Rhode Island, AIDS
Care , 1998, Vol. 10 , No. 2, pp. 221-229.
13. Santiago ML, Santiago EG, Hafalla JCR, Manalo, MA, Orantia,
L, Cajima, MNB, Martin C, Cuaresma, C, Dominguez CE, Borromeo ME,
Anne S. De Groot , Flanigan TP, Carpenter CJ, Mayer KH, Ramirez
B, Molecular Epidemiology of HIV-1 Infection in the Phillippines,
1985-1997: Transmission of Subtypes B and E and Potential Emergence
of Subtypes C and F, J. AIDS and Hu Retrovirology, 1998, Vol. 18,
No. 3, pp. 260-269.
14. Schafer JA, Jesdale BM, George JA, Kouttab NM, Anne S. De Groot,
Prediction of well-conserved HIV-1 ligands using a Matrix-based
Algorithm, EpiMatrix, Vaccine,1998, Vol. 16, No. 19, pp. 1880-1884.
15. Fink MJ, Goodman, AK, Hight E, Miller- Mack E, Anne S. De Groot,
Critical prevention, critical care: gynecological and obstetrical
aspects of comprehensive HIV prevention and treatment among incarcerated
women. J. Correctional Health Care, 1998, Vol. 5, Issue 2, pp.201-223.
*16. Anne S. De Groot, Leibel SR, Zierler S, A Standard of HIV care
for incarcerated women: Northeastern United States' Experiences.
J. Correctional Health Care,1998, Vol. 5, Issue 2, pp. 139-177.
17. Anne S. De Groot, Leibel SR, Reports from the New England Regional
Symposium on HIV Infection among incarcerated women. J. Correctional
Health Care, 1998, Vol. 5, Issue 2, pp. 125-127. .
18.
Xia Jin, DF Nixon, CGP Roberts, Nixon DF, J Safrit, LQ Zhang, YX Huang,
N Bhardwaj, B Jesdale, A.S. De Groot, RA Koup, Identification of subdominant
cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences,
using dendritic cell stimulation and computer-driven algorithm. AIDS
Res Hu Retroviruses Vol 16, No.1, pp. 67-76, January 2000.
19. A.S. De Groot, Bick, J, Thomas, D, Stubblefield, E, HIV Clinical
Trials in Correctional Settings: Right or Retrogression? AIDS Reader.
2001;11(1):34-40.
20. Bond KB, Sriwanthana B, Hodge TW, De Groot AS, Mastro TD, Young
NL, Promadej N, Altman JD, Limpakarnjanarat K, McNicholl JM. An HLA-directed
molecular and bioinformatics approach identifies new HLA-A11 HIV-1
subtype E cytotoxic T lymphocyte epitopes in HIV-1 infected Thais.
AIDS Research and Human Retroviruses 2001; 17(8):703-18.
21. A.S. De Groot, H. Sbai, C. Saint-Aubin, W. Martin, A. Bosma, G.
Skowron, K. H. Mayer Designing HIV-1 vaccines to reflect viral diversity
and the global context of HIV/AIDS. AIDScience 1(2) June 22,2001.
22. A.S. De Groot , Andrew Bosma, N. Chinai, J. Frost, Bill M. Jesdale,
Michael A. Gonzalez, W. Martin, Caitlin Saint-Aubin.From genome to
vaccine: In silico predictions, ex vivo verification Vaccine 2001
Aug 14;19(31):4385-95.
23. A.S. De Groot, Saint Aubin, CS, Rayner, J, Martin, W. Rapid Determination
of HLA B*07- ligands from the West Nile Virus genome. Emerging Infectious
Diseases, Vol. 7, No. 4, July-August 2001: 706-713.
24. H. Sbai, A. Mehta, A.S. De Groot. Use of T cell epitopes for vaccine
development. Current Drug Targets - Infectious Disorders, 2001, 1,
283-293.
25. A.S. De Groot, H. Sbai, C. Saint Aubin, J.A. McMurry, William
Martin. Immuno-informatics: Mining the genome for Vaccine Components.
Immunology and Cell Biology. Immunology and Cell Biology (2002) 80,
255-269. |
| Other
Publications (Chapters, Reviews, Editorials) |
|
1.
Chapter. Raybourne, RB. Hermann, E, Kellner, H, De Groot, A.S.,
Huang, F, Willliams, K.M., Roth, G., Yu, D.T.Y. The role of peptides
in the recognition of HLA-B27 by cytotoxic T cells and by antibodies,
with special emphasis on arthritis patients, Chapter 11 in HLA-B27
in the Development of Spondyloarthropathies. Carlos Lopez Larrea.
R. G. Landes Bioscience, Austin Texas USA.1997.
2. Flanigan TP, Vigilante K, Burzinsky J, Bubly G, Kim J, Cu-Uvin
S, DeCiantis ML, Normandy L, Snead M, A.S. De Groot, DeBuono BA,
Medical Care of HIV-Infected Prisoners: The Rhode Island Experience,
in AIDS Clinical Research and Care: Meeting the Challenges of an
Epidemic in Flux, PRIM&R Conference Proceedings Oct 29-30, 1992.
3. A.S. De Groot, Scheib RG, McGowan K, Schmid CP, Lieberman J,
Wyler DJ, T-cell responses to Mycobacterium tuberculosis antigens
in the HIV-infected host. Vaccines 93, Cold Spring Harbor Press,
Cold Spring Harbor, NY, pp. 251-257.
4. A.S. De Groot, Jesdale BM, Meister GE, Muni N, Roberts CGP, Prediction
of T Cell Epitopes for HIV vaccine development by computer-driven
algorithm, in HIV Molecular Immunology Database 1995, Bette Korber,
Gerald Meyers eds., Los Alamos National Laboratories, New Mexico,
pp. iv17 - iv28.
5. Flanigan TP, Bury-Maynard D, Vigilante K, Burzinsky J, Bubly
G, Kim J, Rich JD, Zierler S, DeCiantis DL, Normandy L, Snead M,
A.S. De Groot, Loberti P, DeBuono BA, The Rhode Island Prison Release
Program, in Progress and Challenges in Linking Incarcerated Individuals
with HIV/AIDS to Community Services, Health Resources and Services
Administration Bureau of Health Resources Development Office of
Science and Epidemiology, June 1995.
6. A.S. De Groot, Meister GE, Roberts CGP, Edelson BT, Ramirez B,
Berzofsky JA, Algorithms for Mycobacterial Vaccine Development,
Proceedings of the International symposium on Bovine TB in Animals
and Human Beings, USDA/NIAID, NIH, 1995.
7. A.S. De Groot, Carter EJ, Roberts CGP, Edelson BT, Jesdale BM,
Meister GE, Houghten RA, Montoya J, Romulo RC, Berzofsky JA, and
Ramirez BDLL, A novel algorithm for the efficient identification
of T cell epitopes: prediction and testing of candidate TB vaccine
peptides in genetically diverse populations, Vaccines 96, Cold Spring
Harbor Laboratory, Cold Spring Harbor, NY, pp. 127-134.
8. Chapter. A.S. De Groot, Meister GE, Cornette JL, Margalit H,
DeLisi C, and Berzofsky JA; Computer Prediction of T Cell Epitopes,
in New Generation Vaccines, 2nd edition, Myron M. Levine, Graeme
C. Woodrow, James B. Kaper, Gary S. Cobon, eds., Marcel Dekker Inc.
NYC, NY, 1996.
9. Jesdale BM, Deocampo G, Meisell J, Mullen L, Beall J, Marinello
M, A.S. De Groot, Matrix-based prediction of MHC-binding peptides:
the Epimatrix algorithm, reagent for HIV research, Vaccines 97,
pp. 57-64, Cold Spring Harbor Laboratory Press 1997.
10. Review. A.S. De Groot, Hammett TM, Scheib RG, Barriers to Care
of HIV-Infected inmates: a public health concern, AIDS Reader, 1996,
May / June, pp. 78-87.
11. Review. A.S. De Groot, HIV infection among incarcerated women:
Epidemic behind bars. AIDS Reader 2000;10:287-295.
12. Review of Proceedings. A.S. De Groot, Leibel SR, Reports from
the New England Regional Symposium on HIV Infection among incarcerated
women. J. Correctional Health Care, 1998, Vol. 5, Issue 2, pp. 125-127.
13. Chapter. A.S. De Groot and Debi Cuccinelli, Put her in a cage:
Childhood sexual abuse, incarceration, and HIV infection, chapter
in The Gender Politics of HIV in Women: Perspectives on the Pandemic
in the United States J. Manlowe and N. Goldstein, ed., New York
University Press, 1997.
14. Nguyen, KB, Suri, PK, Shah, AM, Goldberg, M, De Groot, AS, and
Knopf, PM. Differential immune responses against a Schistosoma mansoni
candidate vaccine antigen in three murine strains. Vaccines 97,
213-217.
15. Chapter. A.S. De Groot, Jesdale BM, Berzofsky JA, Prediction
and determination of MHC ligands and T Cell Epitopes, Chapter 3,
Immunology Methods, SHE Kaufmann, ed, Methods in Microbiology, Vol
25, p 79-106, Academic Press, NY 1998.
16. Review. A.S. De Groot, Leibel SR, The need for Compassionate
Care: HIV Infection Among Incarcerated Women, Medicine and Health,
RI, Vol 81. No. 6, p 209-211, 1998.
17. Review. A.S. De Groot, Stevens J, Pratt L, Leibel SR, Zierler
S, Setting the Standard for Care: HIV Risk Exposures and Clinical
Manifestations of HIV in Incarcerated Massachusetts Women, New England
Journal of Criminal and Civil Confinement, Vol 24, pp 353-378, July
1998.
18. Book Review. De Groot, A. Breaking down the Walls. Lancet, March
27 1999. 353. pp9158.
19. Editorial. A.S. De Groot and Rothman FG, In Silico Predictions;
in Vivo Veritas (News and Views), Nature Biotechnology Vol 17, No.
6, pp. 533-34, June 1999.
20. Editorial. De Groot AS. Shedding light on correctional HIV care.
AIDS Reader 2000;10:285-286.
21. Review of Proceedings. A.S. De Groot , Jackson, EH, Stubblefield,
S. Clinical Trials in Correctional Settings: Proceedings of a conference
held in Providence, RI, Oct 14-15 1999. Rhode Island Journal of
Medicine, 83; (12) December, 2000, pp 376-379.
22.
Commentary. A.S. De Groot, Women Prisoners with HIV: An Open Letter
from a Prison Doctor (1996). In Correctional Perspectives: Views
from Academics, Practitioners, and Prisoners edited by Paul Cromwell
and Leanne Fiftal Alarid, Roxbury Publishing Company. 2001.
23. Scientific Working Group on Tuberculosis. Recommendations. UNDP/World
Bank/WHO Special Programme for Research & Training in Tropical Diseases
(TDR) 9-11 February 2000, Geneva, Switzerland
http://www.who.int/tdr/publications/publications/pdf/tb-swg.pdf
24. Commentary. De Groot AS. Women incest survivors in prison. An
open letter from a prison doctor to those who care for women living
with HIV. Posit Aware. 2001 Jul-Aug;12(4):27-9.
25. Review. De Groot AS. Alarming statistics about incarcerated
women. Posit Aware. 2001 Jul-Aug;12(4):19-21.
26.
Editorial: Learning From the Past, Planning for the Future-DOT for
HIV Infection. The AIDS Reader. 2002 Jul;12(7):314-5.
27. Chapter. A.S. De Groot, H. Sbai, Bill Martin, and Jay A. Berzofsky.
Use of bioinformatics to predict MHC ligands and T-cell epitopes:
Application to vaccine design. Methods in Microbiology: Immunology
of Infection, 2nd Edition. (Volume 32 in the Methods in Microbiology
series). Edited by Stefan Kaufmann and Dieter Kabelitz. [In press].
|
| In
Progress |
|
A.S. De Groot, J. Rayner, W. Martin. Modeling the immunogenicity
of therapeutic proteins using T cell epitope mapping. Developments
in Biologicals. Anthony Mire Suis, editor, Submitted [March 2002).
Chapter. H. Sbai, A. S. De Groot, J. Sidney, A. Sette and Jay A.
Berzofsky. High throughput informatics and in vitro assays for T
cell epitope determination: Application to the design of epitope-driven
vaccines. New Generation Vaccines, 3rd edition, Myron M. Levine,
B. Kaper, Rino Rappuoli, Margaret Liu, Michael Good, ed.s, Marcel
Dekker Inc. NYC, NY. Submitted [ March 2002].
W. Martin, A. Bosma, H. Sbai and A.S. De Groot. The use of bioinformatics
for identifying class I restricted T cell epitopes. Methods issue
on Epitope Mapping. Bill Kwok, editor. Submitted [June 22,2002).
A.S.
De Groot and Bill Martin. Genome-Derived Vaccines. Nature Reviews
Immunology (Invited Review). Jennifer Bell, Editor. Submitted [July
26, 2002].
A.S.
De Groot, Bill Jesdale, W. Martin, C. Saint Aubin, H. Sbai, A. Bosma,
Judy Lieberman, G.A. Skowron, Fadi Mansourati, Ken Mayer. Mapping
Cross-clade HIV-1 Vaccine Epitopes Using a Bioinformatics Approach.
Vaccine. Re-Submitted [August 2002].
Anne S. De Groot, Vishvanath Nene, Nagendra R. Hedge, S. Srikumaran,
James Rayner and William Martin. T Cell Epitope Identification for
Bovine Vaccines: An Epitope Mapping Method for BoLA A-11. International
Journal for Parasitology (Thematic Issue on Vaccines, David Brake
Editor, Submitted [ August 2002].
|
| Abstracts/poster
presentations |
1.
Anne S. De Groot, Clerici M, Hosmalin A., Barnd D, Hughes S, Hendrix
JA, Houghten R, Shearer GM, Berzofsky JA, Identification of a T-Helper
cell epitope in HIV reverse transcriptase which is also recognized
by CTL, poster and abstract, New Approaches to Vaccines, Cold Spring
Harbor Laboratory September, 1991.
2. Gozansky W, Anne S. De Groot, Noble J, Scheib RJ, Griffiths JK,
Wong JB, Prophylactic therapy for Toxoplasma Infection in HIV-1 Seropositive
Subjects: Decision Analysis, poster and abstract, IX International
conference on AIDS, Berlin, 1993.
3. Gozansky W, Schmid CP, Moody S, Cheeseman S, McGowan K, Anne S.
De Groot, A Prospective Study of the Incidence of Reactivation of
Latent Toxoplasma Infection in HIV-1-Seropositive Subjects in Massachusetts,
poster and abstract, IX International Conference on AIDS, Berlin,
June 1993.
4. Anne S. De Groot, Woo D, Meister GE, Berzofsky JA, Identification
of antigenic regions of Mycobacterium tuberculosis proteins using
Natural Peptide and Amphi algorithms, poster and abstract, Conference
on MultiDrug Resistant TB, Bethesda, MD September, 1993.
5. Anne S. De Groot, Shinde SR, Roberts CGP, Haskal R, Meister GE
,Lieberman J, A comparison of Cell-mediated responses to Mycobacterium
tuberculosis (Mtb) antigens in Mtb-immune subjects and HIV-seronegative
and HIV-seropositive Mtb-susceptible subjects, poster and abstract,
New Approaches to Vaccines including AIDS, Cold Spring Harbor Laboratory
September, 1993.
6. Anne S. De Groot, Meister GE, Roberts CGP, Edelson BT, De Groot
LJ, Berzofsky JA, Two novel algorithms for the identification of T
cell epitopes that are based on MHC binding motifs poster and abstract,
Molecular Approaches to the Control of Infectious Diseases, Cold Spring
Harbor Laboratory, October 1994.
7. Meister GE, Roberts CPG, Berzofsky JA, Anne S. De Groot. Mycobacterium
tuberculosis peptide epitopes predicted by two novel epitope identification
algorithms presentation and abstract, Molecular Approaches to the
Control of Infectious Diseases, Cold Spring Harbor Laboratory, Long
Island, New York, October 1994.
8. Roberts CGP, Meister GE, Berzofsky JA, Anne S. De Groot, Peptide
epitopes for five HIV-1 proteins predicted by a novel T cell epitope
prediction algorithm, poster and abstract, NCDVG conference, Washington
DC, October 1994.
9. Anne S. De Groot, Meister GE, Roberts CGP, Edelson BT, De Groot
LJ, Berzofsky JA, Two novel algorithms for the identification of T
cell epitopes that are based on MHC binding motifs, poster and abstract,
Molecular Approaches to the Control of Infectious Diseases Cold Spring
Harbor Laboratory, October 1994.
10. Meister GE, Roberts CGP, Berzofsky JA, Anne S. De Groot. Mycobacterium
tuberculosis peptide epitopes predicted by two novel epitope identification
algorithms, poster and abstract, Molecular Approaches to the Control
of Infectious Diseases, Cold Spring Harbor Laboratory, Long Island,
New York, October 1994.
11. Stevens J, Zierler S, Cram V, Dean D, Mayer KH, Anne S. De Groot,
The Prevalence of HIV, Risks for HIV Infection, and Gynecological
Comorbidity in Women Incarcerated in Massachusetts, poster and abstract,
Conference on Women's Health, Washington DC, June 1994.
12. Anne S. De Groot, Kimberly Fisher, Caroline G.P. Roberts, Gabriel
E. Meister, Brian T. Edelson, Katherine McGowan, John Phair, Ken Mayer,
T cell response to Tuberculosis in HIV seropositive subjects; longitudinal
and cross-sectional analysis, poster and abstract, Keystone Symposium
on the Molecular Mechanisms of Tuberculosis, February 1995. J. Biol.
Chem., suppl 19B: abstract B3 402, 1995.
13. Anne S. De Groot, Fisher K, Roberts CGP, Meister GE, Edelson BT,
McGowan K, Phair J, Mayer K, T cell response to Tuberculosis in HIV
seropositive subjects; longitudinal and cross-sectional analysis,
Poster and abstract, Keystone Symposium on the Molecular Mechanisms
of Tuberculosis, February 1995. J. Biol. Chem., 1995, suppl 19B: abstract
B3 402.
14. Anne S. De Groot, Stevens J, Cram V, Chalfen B, Mayer K, Zierler
K, Childhood sexual abuse increases vulnerability to HIV exposure
among incarcerated women,1st National Congress on HIV in Women, poster
and abstract, Washington DC February 1995.
15. Anne S. De Groot, Stevens J, Chalfen B, Cram V, Dean D, Mayer
K, Zierler S, HIV and gynecological comorbidity among women incarcerated
in Massachusetts, poster and abstract,1st National Congress on HIV
in Women, Washington DC, February 1995
16. Pratt L, Stevens J, Andujar E, Manlowe J, Flanigan T, Zierler
S, Anne S. De Groot; Discharge planning needs of incarcerated women
living with HIV, poster and abstract ,1st National Congress on HIV
in Women, Washington DC February 1995.
17. Gampper, SNR, Nacar E, OíConnell J, Stein M, Fisher AE , Jesdale
W, Carter J, Mayer K, Anne S. De Groot, Co-infection with M. tuberculosis
and HIV-1 in Providence, poster and abstract, American Thoracic Society
Meeting, Seattle WA, May 1995.
18. Renaud T, Carter J, Jesdale BM, Anne S. De Groot, Reducing the
risk of tuberculosis transmission in the prison setting through the
use of environmental controls including UVG Irradiation and HEPA filtration,
poster and abstract, Lancet Tuberculosis Conference, Sept 14-15, 1995,
Washington DC.
19. Anne S. De Groot, Wong S, O'Connell J, Nacar L, Meister GE, Jesdale
BM, Carter J , Use of pediatric tuberculosis infection as a marker
of tuberculosis transmission in communities in Providence, Rhode Island,
poster and abstract, Lancet Tuberculosis Conference, Sept 14-15, 1995,
Washington DC..
20. Anne S. DeGroot, Stevens J, Dean D, Cram V, Andujar E, George
JA , Goodman AK, Poutsiaka DD, Scheib RG, Cohen JL, Health services
for HIV seropositive incarcerated women: The Framingham model, poster
and oral presentation at the National Commission on Correctional Health
Care 19th conference, November 12-13, 1995.
21. Renaud R, Carter J, Jesdale BM, Anne S. De Groot, Reducing the
risk of tuberculosis transmission in the prison setting through the
use of environmental controls: A cost benefit analysis, poster and
oral presentation at the National Commission on Correctional Health
Care 19th conference, November 12-13, 1995.
22. Nguyen KB, George JA, Dong KL, Corah T, Whittle H, Jesdale BM,
Anne S. De Groot, Designing a subunit vaccine for M. tuberculosis
using a novel epitope prediction algorithm: Gambian responses to population
weighted vs unweighted peptides, poster and abstract, Molecular Approaches
to the Control of Infectious Diseases Cold Spring Harbor Laboratory,
September 1996.
23. Anne S. DeGroot, Zierler, S,Stevens, J,Dean, D, Ferdinand MM,Jesdale,
BM, George, JA, Scheib RG,.HIV risk behaviors and HIV related morbitidy
in a cohort of incarcerated women in Massachusetts, poster and abstract,
International AIDS Conference, Vancouver, 1996.
24. Schafer JR, Gotch F, Mayer K, Ho D, Koup R, Anne S. De Groot.
The predicted utility of several phase III HIV-1 vaccines for selected
world populations, poster and abstract, Molecular Approaches to the
Control of Infectious Diseases Cold Spring Harbor Laboratory, September
1996.
25.Santiago MLO, Hafalla JCR, Jesdale BM, Ramirez BDLL, Anne S. De
Groot, Identification ofPhlogenetically conserved clusters of published
and predicted HIV 1 CD8+ CTL epitopes in geographically diverse populations,
poster and abstract, presentation #98.009. International Infectious
Disease society meeting, Hong Kong, June 1996.
26. Natividad M, Cajimat B, Santiago MLO, Hafalla JCR, Libranda-Ramirez
BDL, Jesdale BM, Anne S. De Groot, Clusters of published HIV-1 CD8+
CTL epitopes: peptide diversity and HLA-dependent population coverage,
poster and abstract, Annual Convention of the Philippine Society for
Biochemistry and Molecular Biology, December 1996.
27. Jesdale BM, Schafer JR, Santiago MLO, Granek JA, Roberts CGP,
Koup RA, Anne S. DeGroot Population-dependent prediction of CTL epitopes
for HIV clades using a computer-driven algorithm, poster and abstract,
International AIDS conference, Vancouver, July 1996.
28. Jin X, Nixon DF, Roberts CGP, Safrit J, Zhang LQ, Huang YX, Jesdale
BM, Anne S. DeGroot, Koup RA, Prediction and validation of HLA-B7
restricted CTL epitopes based on upon autologous HIV-1 sequences,
poster and abstract, Keystone HIV/AIDS Pathogenesis meeting, Keystone,
Colorado,1997.
29. Bond K, Pau CP, Malegam JY, Anne S. DeGroot, Szu E, Hodge TW,
Mastro TD, Stephens H, McNicholl JM, HLA-A11 Cytotoxic T Lymphocyte
Epitopes in HIV-1 env Subtype E,poster and abstract, Keystone HIV/AIDS
Pathogenesis meeting, 1997.
30. Anne S. De Groot, Jesdale BM, Szu E, Mullen L, Deocampo D,.Matrix-based
definition of MHC ligands from primary HIV-1 and HIV-2 protein sequences:
the EpiMatrix/HIV Web Site, poster and abstract, Keystone HIV/AIDS
Pathogenesis meeting, 1997.
31. Barnea JD, Bollinger RC, George JA, Jesdale BM, Anne S. De Groot,
Towards Developing an HIV-1 Vaccine for India: Computer-Driven Prediction
and Analysis of Cytotoxic T-Lymphocyte (CTL) Epitopes, poster and
abstract, First Annual Vaccine meeting (ASM, NIAID), Washington DC
1998.
32. Brichkov I, George JA, Whalen RJ, Anne S. DeGroot, Construction
of a DNA vaccine for TB containing promiscuous T cell epitopes, poster
and abstract, First Annual Vaccine meeting (ASM, NIAID, NFID), Washington
DC 1998.
33. Bond KB, Pau CP, Malegam JY, Anne S. DeGroot, Jesdale, BM, Hodge
TW, Mastro TD, McNicholl SH, HLA-A11 Cytotoxic T Lymphocyte Epitopes
in HIV-1 env Subtype E, poster and oral presentation at the International
AIDS Conference, Geneva, June1998.
34. Anne S. De Groot, Jesdale BM, Fleischmann RD, Matrix based prediction
of MHC binding peptides: the TIGR/EpiMatrix website, reagent for TB
research, poster and abstract, Conference on TB: Molecular mechanisms
and Immunopathogenesis, Keystone, Colorado, April 1998.
35. Anne S. De Groot, Schafer JR, Barnea JD, George JA, Jesdale BM,
Evaluation of HIV sequences for MHC binding patterns by computer driven
algorithm, poster and abstract, HIV Evolution Meeting, Santa Fe, NM,
April 1998.
36. Anne S. DeGroot , George JA, Gonzalez M, Chinai N, Genome to T
Cell: Epitope-Driven Vaccine Design, abstract and oral presentation,
Microbial Genomes Conference, Chantilly, VA, January 1999.
37. Anne S. DeGroot, George J, Gonalez M, Jin X, Bond K, Koup R, McNicholl
J, Prospective Identification of MHC Ligands and CTL Epitopes from
HIV Proteins using Bioinformatics, Abstract number 43, Accepted as
poster and oral presentation at the 6th conference on Retroviruses
and Opportunistic Infections, Chicago, IL, January 1999.
38. Anne S. De Groot, Gonzalez M, Chinai N, Barnea JD, George JA,
From Genome to T Cell: Searching for Agretopes, poster and abstract,
Second Annual Vaccine meeting (ASM, NIAID, NFID), Washington DC 1999.
|
| |
|
|
|
